Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers

Mar.31
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao argues that nicotine pouches are no longer a niche alternative, but a force quietly reshaping the future of tobacco retail. For distributors and retailers, the real risk is not missing a trend—it is moving too late, after regulation tightens, shelf space hardens and the market begins to choose its winners.
  • This article was commissioned by Retailers for the Future, a Spanish trade magazine serving the tobacco retail channel, and was published in V.2 [2026] of the magazine. The text presented here is the original English manuscript.
  • This article reflects the author’s personal views only.

 

Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers

Alan Zhao’s commissioned opinion piece for the Spanish tobacco retail magazine Retailers for the Future has been published in V.2 [2026] of the journal.

 

The Role of Nicotine Pouches in the Global Tobacco Alternatives Market

The role of nicotine pouches is no longer peripheral.

 

By Alan Zhao

February 2026

 

In early February, PMI and BAT released their 2025 annual results. PMI’s nicotine pouch shipments rose 36 percent, driven by ZYN in the United States, while BAT’s Modern Oral volumes increased more than 47 percent, led by Velo. This is not incremental growth. It reflects a structural reallocation of industry focus.

 

For over a century, combustion defines tobacco. Over the past two decades, heated products remove fire, e-cigarettes remove the leaf, and nicotine pouches remove smoke—shifting consumption from inhalation to oral absorption and separating nicotine from combustible tobacco.

 

Nicotine pouches expand the geography of use. Without smoke or vapor, consumption becomes discreet and less dependent on space. Workplaces, hospitality venues, and regulated indoor environments that restrict inhaled products represent a fundamentally different context for oral nicotine.

 

Though often framed within harm reduction debates, the category’s immediate relevance for the trade lies in behavioral change—and in the industrial logic that follows. Unlike electronic cigarettes, which depend on device ecosystems and hardware differentiation, nicotine pouches are structurally simpler. They are standardized oral products rather than hardware platforms. In mature markets, retailers will not need dozens of pouch brands. A focused portfolio of three to five strong players can meet most demand. Shelf space is finite; profitability depends on efficiency.

 

Regulation is redefining the terrain. Child-resistant packaging, nicotine strength calibration to prevent unintended overconsumption, and long-term research into oral and gum health are central policy debates. Even within the European Union, divergence is clear. Spain has proposed strict strength and flavor limits, while Nordic countries, drawing on decades of experience with oral nicotine products, take a different view.

 

Regulatory uncertainty introduces volatility. Volatility introduces risk. In transitional markets, risk becomes a sorting mechanism. Those with long-term conviction, operational discipline, and strategic courage gain ground while others hesitate.

 

For brands, the direction is unmistakable. No serious tobacco company can remain confined to combustible products. Nicotine pouches offer one of the fastest and most accessible entry points into next-generation nicotine markets.

 

For distributors, the cycle is clear. In 2025, nicotine pouch brands surge. In 2026, that momentum begins to move downstream. Brand proliferation becomes channel leverage—bringing stronger negotiating power, promotional support, and margin gains for those prepared to manage it.

 

For retailers, engagement does not require radical reinvention. Pouches demand neither complex device displays nor technical servicing. Beginning with a disciplined range allows rapid learning, consumer dialogue, and early authority in a category still defining its structure.

 

Consolidation will follow expansion. Regulatory frameworks will harden. Shelf space will consolidate. The advantage lies not in waiting for clarity, but in positioning before clarity arrives.

 

In a market defined by transition, the greatest risk is not miscalculation—but inertia.


Further reading

 

Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
According to The Maritime Executive on August 19, 2026, the Australian Border Force (ABF) and China’s Anti-Smuggling Bureau of General Administration of China Customs worked together to dismantle an international illicit tobacco smuggling network targeting Australia. According to information released by ABF on August 20, sustained information sharing and cooperation led to investigations into 112 shipping containers, with 91 found to contain illicit tobacco. Authorities seized more than 60 million cigarettes and 60 kilograms of loose-leaf tobacco, representing more than A$92 million in unpaid duties. More than 60 people suspected of involvement in the network were arrested in China.
Aug.20
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22